891 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
3 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
4 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
5 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
6 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
7 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
8 Not yet recruiting A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine
Condition: Prostate Cancer
Intervention: Other: Blood draw
9 Not yet recruiting Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent
Condition: Prostate Cancer Metastatic
Interventions: Drug: cabazitaxel XRP6258;   Drug: enzalutamide;   Drug: abiraterone acetate;   Drug: prednisone
10 Not yet recruiting Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence
Conditions: Prostate Neoplasm;   Prostatectomy;   Surgical Procedures, Robotic;   Urinary Incontinence;   Biofeedback;   Pelvic Floor;   Exercise
Intervention: Device: Extracorporeal biofeedback device (Any Kegel)
11 Not yet recruiting Assessment of Prostate MRI Before Prostate Biopsies
Condition: Prostate Cancer
Intervention: Procedure: Prostate biopsy
12 Recruiting Treatment of Advanced Castration Resistant Prostate Carcinoma With Limited Bone Metastases (α-RT)
Condition: Prostate Carcinoma
Interventions: Drug: Radium-223 dichloride;   Other: Conventional or high dose radiotherapy
13 Recruiting PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: [68Ga]RM2;   Procedure: PET/CT
14 Not yet recruiting Changes of the Hemodynamic Profiles on Bio Reactance Technique During TURP in Elderly Patients
Condition: Benign Prostate Hyperplasia
Intervention:
15 Not yet recruiting Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer
Condition: Prostate Cancer
Intervention: Other: Exercise
16 Not yet recruiting Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Burixafor Hydrobromide;   Drug: Docetaxel;   Drug: G-CSF
17 Not yet recruiting Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI)
Condition: Prostate Cancer
Intervention: Device: Biodegradable balloon implant
18 Not yet recruiting Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer
Condition: Prostate Cancer
Intervention: Device: smartphone or tablet
19 Not yet recruiting Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists
Conditions: Prostatic Neoplasms;   Cardiovascular Diseases
Interventions: Drug: Degarelix (LHRH antagonist);   Drug: LHRH agonist;   Device: EndoPAT2000
20 Recruiting PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer
Conditions: Stage I Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Drug: Antiandrogen Therapy;   Other: Laboratory Biomarker Analysis;   Drug: Multitargeted Tyrosine Kinase Inhibitor PLX3397;   Radiation: Radiation Therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years